Integris Grove Hospital
Integris Grove Hospital was paid $5.80M by Medicaid between Jan 2018 and Dec 2024, across 67 billing codes. Its largest line is 99283, emergency room visit (moderate) — 54% of everything it billed.
GROVE, OK 74344
Next to other General Acute Care Hospital providers in Oklahoma
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,619 | $691K | |
| 2019 | 6,436 | $594K | |
| 2020 | 5,637 | $482K | |
| 2021 | 10,374 | $815K | |
| 2022 | 15,563 | $1.23M | |
| 2023 | 16,297 | $1.31M | |
| 2024incomplete | 7,700 | $686K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 54% | 19,403 | 19,181 | $3.15M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 16% | 4,184 | 4,133 | $954K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.9% | 1,884 | 1,852 | $577K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.0% | 1,383 | 1,352 | $173K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 2.2% | 141 | 141 | $125K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.2% | 778 | 772 | $72K |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,017 | 5,708 | $57K |
| 80053 | Comprehensive metabolic panel | <1% | 3,352 | 3,211 | $55K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,478 | 3,196 | $48K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,708 | 2,647 | $47K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 326 | 323 | $43K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 1,154 | 1,148 | $42K |
55 more codes
| 87400 | <1% | 1,368 | $39K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 463 | $35K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 590 | $31K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 223 | $30K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,798 | $25K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 629 | $25K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 128 | $22K |
| 83690 | <1% | 672 | $18K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 897 | $18K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 197 | $17K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 277 | $15K |
| 84484 | <1% | 976 | $15K | |
| 83880 | <1% | 379 | $14K | |
| 81003 | <1% | 1,641 | $14K | |
| 87430 | <1% | 841 | $14K | |
| 85610 | <1% | 703 | $14K | |
| 85027 | <1% | 1,454 | $13K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 150 | $13K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,256 | $10K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 190 | $9K |
| 87070 | <1% | 746 | $7K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,776 | $7K |
| 81001 | <1% | 2,303 | $7K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 60 | $6K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 747 | $5K |
| 80179 | <1% | 318 | $5K | |
| 80143 | <1% | 318 | $5K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 37 | $5K |
| 81025 | <1% | 544 | $4K | |
| 83655 | <1% | 344 | $4K | |
| 73630 | <1% | 211 | $4K | |
| 73110 | <1% | 106 | $3K | |
| 87807 | <1% | 194 | $2K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 92 | $2K |
| 87420 | <1% | 99 | $1K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 27 | $1K |
| 88304 | <1% | 27 | $1K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 14 | $1K |
| 85018 | <1% | 419 | $819.01 | |
| 73562 | <1% | 48 | $783.43 | |
| 81002 | <1% | 125 | $372.09 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 32 | $364.87 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 188 | $268.64 |
| 85730 | <1% | 39 | $187.25 | |
| 87040 | <1% | 12 | $184.04 | |
| 87210 | <1% | 28 | $137.11 | |
| 86850 | <1% | 12 | $104.28 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 12 | $91.68 |
| 85379 | <1% | 13 | $81.45 | |
| 88720 | <1% | 16 | $71.52 | |
| 86900 | <1% | 12 | $31.92 | |
| 86901 | <1% | 12 | $31.92 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 30 | $2.41 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 13 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Integris Miami Hospital | Miami, OK | $7.24M |
| Integris Canadian Valley Hospital | Yukon, OK | $7.12M |
| Integris Bass Baptist Health Center | Enid, OK | $6.42M |
| Integris Health Ponca City Hospital INC | Ponca City, OK | $818K |
| Integris Grove Hospital | Grove, OK | $444K |
| Integris Bass Baptist Health Center | Medford, OK | $376K |
| Integris Bass Baptist Health Center | Waynoka, OK | $303K |
| Integris Health Ponca City Hospital INC | Ponca City, OK | $79K |
| Integris Health Woodward Hospital INC | Woodward, OK | $71K |
| Integris Health Woodward Hospital INC | Woodward, OK | $68K |
| Integris Health Woodward Hospital INC | Woodward, OK | $32K |
| Integris Health Woodward Hospital INC | Woodward, OK | $19K |
| Integris Health Woodward Hospital INC | Mooreland, OK | $6K |
| Integris Health Woodward Hospital INC | Woodward, OK | $5K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.